These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5435648)

  • 1. The syndrome of primary aldosteronism.
    George JM; Wright L; Bell NH; Bartter FC
    Am J Med; 1970 Mar; 48(3):343-56. PubMed ID: 5435648
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 3. Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
    Davis WW; Newsome HH; Wright LD; Hammond WG; Easton J; Bartter FC
    Am J Med; 1967 Apr; 42(4):642-7. PubMed ID: 6024721
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current problems in primary aldosteronism--4 cases of normokalemic primary aldosteronism (1st degree) caused by adenoma and 3 cases of aldosteronism, 1st degree, caused by hyperplasia (2 hypokalemic cases, a normokalemic case)].
    Oda T
    Naika; 1969 Oct; 24(4):713-24. PubMed ID: 5358678
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome).
    Brackett NC; Koppel M; Randall RE; Nixon WP
    Am J Med; 1968 May; 44(5):803-19. PubMed ID: 4297214
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative diagnosis of primary aldosteronism, including a comparison of operative findings and preoperative tumor localization by adrenal phlebography.
    Conn JW; Rovner DR; Cohen EL; Bookstein JJ; Cerny JC; Lucas CP
    Arch Intern Med; 1969 Feb; 123(2):113-23. PubMed ID: 5763613
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypokalemic alkalosis with hyperplasia of the juxtaglomerular apparatus: Bartter's syndrome?].
    Codaccioni JL; Boyer J; Jubelin J; Conte-Devolx B; Hebreard J
    Ann Endocrinol (Paris); 1972; 33(3):281-4. PubMed ID: 4346620
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A
    J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 11. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
    Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
    [No Abstract]   [Full Text] [Related]  

  • 13. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 15. Triamterene-thiazide combination: alternative therapy for primary aldosteronism.
    Ganguly A; Weinberger MH
    Clin Pharmacol Ther; 1981 Aug; 30(2):246-50. PubMed ID: 7018790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies on the urinary excretion of aldosterone in myasthenia gravis].
    Nakamoto M
    Nihon Naibunpi Gakkai Zasshi; 1967 Nov; 43(8):770-84. PubMed ID: 5626257
    [No Abstract]   [Full Text] [Related]  

  • 17. [An observation of Conn's syndrome. Clinical and biological study].
    Tourniaire J; Revol A; Maret G; Blanc-Brunat N
    Rev Fr Endocrinol Clin; 1968; 9(4):333-50. PubMed ID: 4302797
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary aldosteronism: a review of 8 cases.
    Moore RJ; Hodges CV
    J Urol; 1968 Sep; 100(3):201-4. PubMed ID: 5677034
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical studies on the acid-base balance disturbance in congestive heart failure.
    Awamura M
    Jpn Circ J; 1969 Mar; 33(3):275-91. PubMed ID: 5819413
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with primary aldosteronism.
    Tremann JA; Gibbons RP; Correa RJ
    J Urol; 1973 Jul; 110(1):6-8. PubMed ID: 4713362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.